Article
Development and Validation of a Genotypic Assay to Quantify CXCR4- and CCR5-Tropic Human Immunodeficiency Virus Type-1 (HIV-1) Populations and a Comparison to Trofile®.
Viruses - 27 Mar 2024
Ko Daisy, McLaughlin Sherry, Deng Wenjie, Mullins James I, Dragavon Joan, Harb Socorro, Coombs Robert W, Frenkel Lisa M
Abstract excerpt
HIV-1 typically infects cells via the CD4 receptor and CCR5 or CXCR4 co-receptors. Maraviroc is a CCR5-specific viral entry inhibitor; knowledge of viral co-receptor specificity is important prior to usage. We developed and validated an economical V3-env Illumina-based assay to detect and quantify the frequency of viruses utilizing each co-receptor. Plasma from 54 HIV+ participants (subtype B) was tested. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
